Stability of extemporaneously prepared moxifloxacin oral suspensions

American Journal of Health-System Pharmacy

Volumn 66, Issue 7, 2009, Pages 665-667

  Hutchinson, David J ^a   Johnson, Gary E ^b,c,e   Klein, Kristin C ^c,d  

^a ST JOHN FISHER COLLEGE   (United States)

^b Department of Pharmacy Practice

^c UMHHC   (United States)

^d Department of Pharmacy Practice   (United States)

^e UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Chromatography; Compounding; Concentration; Liquid; Moxifloxacm; Qumolones; Stability; Storage; Suspensions; Vehicles

Indexed keywords

EXCIPIENT; MOXIFLOXACIN;

ARTICLE; DILUTION; DRUG DETERMINATION; DRUG FORMULATION; DRUG STABILITY; DRUG STORAGE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; PRIORITY JOURNAL;

EID: 63449141574     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.2146/ajhp080152     Document Type: Article

References (6)

1. Keating GM, Scott LJ. Moxifloxacin: a review of its use in the management of bacterial infections. Drugs. 2004; 64:2347-77.
2. Avelox (moxifloxacin) package insert. West Haven, CT: Bayer Health Care; 2007 Jul.
3. Johnson CE, Wong DV, Hoppe HL et al. Stability of ciprofloxacin in an extemporaneous oral liquid dosage form. Int J Pharm Comp. 1998;2:314-7.
4. VandenBussche HL, Johnson CE, Fontana EM et al. Stability of levofloxacin in an extemporaneously compounded oral liquid. Am J Health-Syst Pharm. 1999; 56:2316-8.
5. Johnson CE, Price J, Hession JH. Stability of norfloxacin in an extemporaneously prepared oral liquid. Am J Health-Syst Pharm. 2001;58:577-9.
6. Cordoba-Borrego M, Cordoba-Diaz M, Cordoba-Diaz D. Validation of a high-performance liquid chromatographic method for determination of norfloxacin and its application to stability studies. J Pharm Biomed Anal. 1999; 18:919-26.